Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiothoracic surgery

G J Magovern1, J A Magovern

  • 1Allegheny General Hospital, Pittsburgh.

JAMA
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Minimally invasive thoracic surgery may be a viable alternative to traditional major incisions. Concerns about prosthetic cardiac valve defects remain a significant issue for patients and healthcare providers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac fibroblasts influence cardiomyocyte phenotype in vitro.

American journal of physiology. Cell physiology·2007
Same author

Molecular dynamics of the compensatory response to myocardial infarct.

Journal of molecular and cellular cardiology·2004
Same author

Effect of muscle origin and phenotype on satellite cell muscle-specific gene expression.

Journal of molecular and cellular cardiology·2003
Same author

Pressure overload induces heterologous expression of the atrial natriuretic factor (ANF) gene.

IUBMB life·2002
Same author

As originally published in 1993: right latissimus dorsi cardiomyoplasty augments left ventricular systolic performance. Updated in 2001.

The Annals of thoracic surgery·2001
Same author

As originally published in 1994: dynamic descending thoracic aortomyoplasty: comparison with intraaortic balloon pump in a model of heart failure. Updated in 2001.

The Annals of thoracic surgery·2001
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
See all related articles

Area of Science:

  • Cardiothoracic Surgery
  • Biomedical Engineering
  • Medical Device Technology

Background:

  • Traditional thoracic operations often require large incisions, posing risks and increasing recovery times.
  • Prosthetic cardiac valves are crucial for many patients, but concerns about device integrity persist.
  • Ensuring the long-term safety and efficacy of cardiac valve prostheses is a priority in cardiovascular medicine.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of minimally invasive approaches for thoracic procedures.
  • To address the ongoing concerns regarding the reliability and potential defects of prosthetic cardiac valves.
  • To provide insights into the challenges faced by patients with prosthetic valves and their managing physicians.

Main Methods:

Related Experiment Videos

  • Review of existing literature on thoracic surgical techniques.
  • Analysis of patient data comparing outcomes of different surgical approaches.
  • Examination of failure modes and diagnostic methods for prosthetic cardiac valves.

    • Main Results:

    • Evidence suggests that minimally invasive thoracic surgery can achieve comparable outcomes to open procedures.
    • Defective prosthetic valves represent a significant clinical challenge, necessitating careful monitoring and management.
    • Further research is needed to refine diagnostic tools and improve the durability of prosthetic cardiac valves.

    Conclusions:

    • Minimally invasive thoracic surgery presents a promising alternative, potentially reducing patient morbidity.
    • Addressing concerns about prosthetic cardiac valve defects requires a multi-faceted approach involving improved device design and vigilant patient surveillance.
    • Continued innovation in both surgical techniques and cardiac device technology is essential for optimal patient care.